Characteristic | Intervention (n = 905) | Usual care (n = 927) |
---|---|---|
Male, n (%) | 575 (63.5) | 589 (63.5) |
Mean age, years (SD) | 62.1 (7.9) | 62.4 (7.7) |
Height, cm (SD) | 166.9 (9.3) | 167.4 (9.1) |
Weight, kg (SD) | 85.8 (16.5) | 85.6 (15.9) |
Body Mass Index, kg/m2 (SD) | 30.7 (5.2) | 30.5 (5.0) |
Men with waist ≥ 102 cm, n (%) | 358 (62.8) | 385 (66.3) |
Women with waist ≥ 88 cm, n (%) | 279 (85.6) | 278 (85.3) |
Mean systolic blood pressure, mmHg (SD)a | 145.9 (15.3) | 138.7 (13.5) |
Mean diastolic blood pressure, mmHg (SD)a | 83.7 (11.7) | 80.6 (9.2) |
Heart rate, beats/min (SD) | 71.4 (10.9) | 71.6 (10.4) |
Total cholesterol, mmol/l (SD) | 5.27 (1.15) | 5.29 (1.14) |
HDL, mmol/L (SD) | 1.30 (0.35) | 1.32 (0.37) |
LDL, mmol/L (SD) | 3.19 (1.02) | 3.21 (1.04) |
Triglyceride, mmol/L (SD) | 1.84 (1.19) | 1.78 (1.00) |
Creatininemia μmol/L (SD) | 86.2 (29.9) | 85.4 (25.5) |
MDRD-estimated glomerular filtration rate, ml/min (SD) | 79.6 (19.6) | 80.8 (20.2) |
Fasting glycemia, mmol/l (SD) | 6.88 (1.94) | 6.77 (1.94) |
Left ventricular hypertrophy, n (%) | 150 (16.6) | 184 (19.9) |
Family history of early cardiovascular event, n (%) | 225 (24.9) | 253 (27.3) |
Albuminuria ≥ 20 mg/L, n (%) | 186 (22.3) | 154 (18.1) |
Mean years since diagnosis of hypertension (SD) | 10.5 (7.8) | 11.2 (8.3) |
Smoker status | Â | Â |
  Current n (%) | 193 (21.3) | 217 (23.4) |
  Past smoker < three years n (%) | 72 (8.0) | 94 (10.2) |
  Non-smoker n (%) | 640 (70.7) | 615 (66.4) |
Number of antihypertensive drugs, n (SD) | 2.16 (1.04) | 2.18 (1.04) |
Type-2 diabetes, n (%) | 527 (58.2) | 521 (56.2) |
Mean years since diagnosis of type-2 diabetes, (SD) | 6.9 (6.1) | 7.8 (6.9) |
HbA1c, % (SD) | 7.0 (1.1) | 7.0 (1.2) |
Cardiovascular risk factors, n (%) | Â | Â |
Men > 50 or women > 60 years old | 779 (86.1) | 802 (86.6) |
Current smoker or past smoker < three years | 265 (29.3) | 311 (33.6) |
LDL ≥ 4.14 mmol/L or treatment | 692 (76.5) | 686 (74.0) |
HDL ≤ 1.04 mmol/L | 189 (20.9) | 190 (20.6) |
Number of cardiovascular risk factors, n (%) | Â | Â |
  ≤ 2 | 259 (28.6) | 264 (28.5) |
  3 | 319 (35.2) | 315 (34.0) |
  4 | 222 (24.5) | 247 (26.6) |
  ≥ 5 | 105 (11.6) | 101 (10.8) |
Ten-year Framingham-Anderson risk score, (%) | 17.5 | 17.0 |
Achieved all therapeutic targets (3 or 5), n/N (%)a | 56/900 (6.2) | 94/923 (10.2) |
Achieved blood pressure target, n (%)a | 207 (23.0) | 392 (42.6) |
Achieved LDL target, n (%) | 370 (41.1) | 395 (43.4) |
No smoking, n (%) | 712 (78.7) | 709 (76.6) |
Patients with diabetes | Â | Â |
Achieved HbA1c target n/N (%) | 312/527 (60.1) | 316/521 (61.7) |
Low-dose aspirin (yes) n/N (%)a | 225/527 (42.7) | 140/521 (26.9) |